+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biochip Product Market Outlook 2026-2034: by Type (Lab-on-a-chip, Microarray), Application, End-User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6244069
UP TO OFF until Jan 01st 2027
The Biochip Product Market is estimated at US$23.4 billion in 2026 and is projected to grow at a CAGR of 38.4% to reach US$315 billion by 2034.

Market Overview

The Biochip Product Market covers miniaturized biochip products used in defined biological analysis or research workflows.

The target assay and sample requirements determine suitable designs; integration with instruments and data interpretation affect practical value.

Market Segmentation

By Type

  • Lab-on-a-chip
  • Microarray

By Application

  • Clinical Diagnostics
  • Drug Discovery
  • Genomics and Proteomics
  • Others (environmental, food-testing, forensics)

By End-User

  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes

Key Companies Analysed

  • Illumina
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • Roche
  • Standard BioTools
  • Arrayit
  • Merck KGaA
  • Abbott Laboratories
  • GE HealthCare
  • QIAGEN
  • Tecan
  • BioMérieux
  • Shimadzu
  • Axiom Microdevices
  • CapitalBio Technology
  • Randox Laboratories
  • CerTest Biotec

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Biochip Product Market Overview
2.1. Biochip Product Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Biochip Product Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Biochip Product Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Biochip Product Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. Biochip Product Market Analysis By Type, 2025-2034
5.2.1. Lab-on-a-chip
5.2.2. Microarray
5.3. Biochip Product Market Analysis By Application, 2025-2034
5.3.1. Clinical Diagnostics
5.3.2. Drug Discovery
5.3.3. Genomics and Proteomics
5.3.4. Others (environmental, food-testing, forensics)
5.4. Biochip Product Market Analysis By End-User, 2025-2034
5.4.1. Biotechnology & Pharmaceutical Companies
5.4.2. Hospitals & Diagnostic Centers
5.4.3. Academic & Research Institutes
6. North America Biochip Product Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Biochip Product Market Analysis By Type
6.3. North America Biochip Product Market Analysis By Application
6.4. North America Biochip Product Market Analysis By End-User
6.5. North America Outlook By Country
6.5.1. United States
6.5.2. Canada
6.5.3. Mexico
7. Europe Biochip Product Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Biochip Product Market Analysis By Type
7.3. Europe Biochip Product Market Analysis By Application
7.4. Europe Biochip Product Market Analysis By End-User
7.5. Europe Outlook By Country
7.5.1. Germany
7.5.2. United Kingdom
7.5.3. France
7.5.4. Italy
7.5.5. Spain
7.5.6. Netherlands
7.5.7. Switzerland
7.5.8. Poland
7.5.9. Sweden
7.5.10. Russia
8. Asia-Pacific Biochip Product Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Biochip Product Market Analysis By Type
8.3. Asia-Pacific Biochip Product Market Analysis By Application
8.4. Asia-Pacific Biochip Product Market Analysis By End-User
8.5. Asia-Pacific Outlook By Country
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia
8.5.6. Indonesia
8.5.7. Malaysia
8.5.8. Vietnam
9. Middle East and Africa Biochip Product Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Biochip Product Market Analysis By Type
9.3. Middle East and Africa Biochip Product Market Analysis By Application
9.4. Middle East and Africa Biochip Product Market Analysis By End-User
9.5. Middle East and Africa Outlook By Country
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. Iran
9.5.4. United Arab Emirates
9.5.5. Egypt
10. South and Central America Biochip Product Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Biochip Product Market Analysis By Type
10.3. South and Central America Biochip Product Market Analysis By Application
10.4. South and Central America Biochip Product Market Analysis By End-User
10.5. South and Central America Outlook By Country
10.5.1. Brazil
10.5.2. Argentina
10.5.3. Chile
10.5.4. Peru
11. Biochip Product Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Illumina
11.2.2. Thermo Fisher Scientific
11.2.3. Bio-Rad Laboratories
11.2.4. Agilent Technologies
11.2.5. Danaher
11.2.6. PerkinElmer
11.2.7. Roche
11.2.8. Standard BioTools
11.2.9. Arrayit
11.2.10. Merck KGaA
11.2.11. Abbott Laboratories
11.2.12. GE HealthCare
11.2.13. QIAGEN
11.2.14. Tecan
11.2.15. BioMérieux
11.2.16. Shimadzu
11.2.17. Axiom Microdevices
11.2.18. CapitalBio Technology
11.2.19. Randox Laboratories
11.2.20. CerTest Biotec
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Illumina
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Danaher
  • PerkinElmer
  • Roche
  • Standard BioTools
  • Arrayit
  • Merck KGaA
  • Abbott Laboratories
  • GE HealthCare
  • QIAGEN
  • Tecan
  • BioMérieux
  • Shimadzu
  • Axiom Microdevices
  • CapitalBio Technology
  • Randox Laboratories
  • CerTest Biotec

Table Information